Nanobacteria-caused Mitral Valve Calciphylaxis in a Man with Diabetic Renal Failure

Southern Medical Journal

Volumn 97, Issue 2, 2004, Pages 194-198

  Jelic, Tomislav M ^a   Malas, Amer M ^b   Groves, Samuel S ^b   Jin, Bo ^b   Mellen, Paul F ^b   Osborne, Garry ^b   Roque, Rod ^b   Rosencrance, James G ^b   Chang, Ho Huang ^b  

^a CHARLESTON AREA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; CALCIUM CARBONATE; CALCIUM PHOSPHATE; FIBRIN; GENTAMICIN; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; BRAIN INFARCTION; BRONCHOPNEUMONIA; CALCINOSIS; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DISEASE COURSE; DRY SKIN; ELECTRON MICROSCOPY; ENTEROBACTER AEROGENES; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; MITRAL VALVE CALCIPHYLAXIS; MITRAL VALVE DISEASE; MUSCLE BIOPSY; PHYSICAL EXAMINATION; SPECTROMETRY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; CALCIPHYLAXIS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FATAL OUTCOME; GRAM-NEGATIVE BACTERIA; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MITRAL VALVE; PERITONEAL DIALYSIS;

EID: 1242336811     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000077067.44311.F0     Document Type: Article

References (17)

1. Budisavljevic MN, Cheek D, Ploth DW. Calciphylaxis in chronic renal failure. J Am Soc Nephrol 1996;7:978-982.
2. Rosen H, Friedman SA, Raizner AE, et al. Azotemic arteriopathy. Am Heart J 1972;84:250-255.
3. Kajander EO, Kuronen I, Akerman KK, et al. Nanobacteria from blood: The smallest culturable autonomously replicating agent on Earth. Proc SPIE 1997;3111:420-428.
4. Kajander EO, Ciftcioglu N. Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 1998;95:8274-8279.
5. Abbott A. Battle lines drawn between "nanobacteria" researchers. Nature 1999;401:105.
6. Ciftcioglu N, Bjorklund M, Kuorikoski K, et al. Nanobacteria: An infectious cause for kidney stone formation. Kidney Int 1999;56:1893-1898.
7. Hjelle JT, Miller-Hjelle MA, Poxton IR, et al. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 2000;57:2360-2374.
8. Adrogue HJ, Frazier MR, Zeluff B, et al. Systemic calciphylaxis revisited. Am J Nephrol 1981;1:177-183.
9. Kent RB III, Lyerly RT. Systemic calciphylaxis. South Med J. 1994;87:278-281.
10. Torok L, Kozepessy L. Cutaneous gangrene due to hyperparathyroidism secondary to chronic renal failure (uraemic gangrene syndrome). Clin Exp Dermatol 1996;21:75-77.
11. Selye H, Gabbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology 1962;71:554-558.
12. Katsamakis G, Lukovits TG, Gorelick PB. Calcific cerebral embolism in systemic calciphylaxis. Neurology 1998;51:295-297.
13. Janigan DT, Hirsch DJ, Klassen GA, et al. Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure. Am J Kidney Dis 2000;35:588-597.
14. Fine A, Fleming S, Leslie W. Calciphylaxis presenting with calf pain and plaques in four continuous ambulatory peritoneal dialysis patients and in one predialysis patient. Am J Kidney Dis 1995;25:498-502.
15. Levin A, Mehta RL, Goldstein MB. Mathematical formulation to help identify the patient at risk of ischemic tissue necrosis- a potentially lethal complication of chronic renal failure. Am J Nephrol 1993;13:448-453.
16. Stein M, Anderson C, Ricciardi R, et al. Penile gangrene associated with chronic renal failure: Report of 7 cases and review of the literature. J Urol 1994;152:2014-2016.
17. Machovich R. Effect of calcium phosphate on thrombin and on its sensitivity to heparin and antithrombin-III. Thromb Res 1976;9:123-131.